Original language | English (US) |
---|---|
Pages (from-to) | 994-999 |
Number of pages | 6 |
Journal | Nature biotechnology |
Volume | 40 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2022 |
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Applied Microbiology and Biotechnology
- Molecular Medicine
- Biomedical Engineering
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Nature biotechnology, Vol. 40, No. 7, 07.2022, p. 994-999.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Standardized annotation of translated open reading frames
AU - Mudge, Jonathan M.
AU - Ruiz-Orera, Jorge
AU - Prensner, John R.
AU - Brunet, Marie A.
AU - Calvet, Ferriol
AU - Jungreis, Irwin
AU - Gonzalez, Jose Manuel
AU - Magrane, Michele
AU - Martinez, Thomas F.
AU - Schulz, Jana Felicitas
AU - Yang, Yucheng T.
AU - Albà, M. Mar
AU - Aspden, Julie L.
AU - Baranov, Pavel V.
AU - Bazzini, Ariel A.
AU - Bruford, Elspeth
AU - Martin, Maria Jesus
AU - Calviello, Lorenzo
AU - Carvunis, Anne Ruxandra
AU - Chen, Jin
AU - Couso, Juan Pablo
AU - Deutsch, Eric W.
AU - Flicek, Paul
AU - Frankish, Adam
AU - Gerstein, Mark
AU - Hubner, Norbert
AU - Ingolia, Nicholas T.
AU - Kellis, Manolis
AU - Menschaert, Gerben
AU - Moritz, Robert L.
AU - Ohler, Uwe
AU - Roucou, Xavier
AU - Saghatelian, Alan
AU - Weissman, Jonathan S.
AU - van Heesch, Sebastiaan
N1 - Funding Information: A.F., J.M.M., F.C. and P.F. are supported by the Wellcome Trust (grant number 108749/Z/15/Z), the National Human Genome Research Institute (NHGRI) of the US National Institutes of Health (NIH) under award number 2U41HG007234 and the European Molecular Biology Laboratory (EMBL). For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Ensembl is a registered trademark of EMBL. M.G. and Y.T.Y. are supported by NHGRI, NIH, under award number 2U41HG007234. I.J. and M.K. are supported by National Human Genome Research Institute of the NIH under award numbers 2U41HG007234 and R01 HG004037. UniProt is supported by the NHGRI, NIH, under award number (U24HG007822), EMBL core funds and the Swiss Federal Government through the State Secretariat for Education, Research and Innovation (SERI). J.R.P. is supported by the Harvard K-12 in Central Nervous System tumors (5K12 CA 90354-18), the Alex’s Lemonade Stand Foundation Young Investigator Award (no. 21-23983) and the Musella Foundation for Brain Tumor Research. T.F.M. is supported by the NIH under award number F32GM123685. M.M.A. acknowledges funding from the Spanish Government grant PGC2018-094091-B-I00 (MCI/AEI/FEDER, EU) and AGAUR grant 2017SGR01020. J.C. is supported by the NIH Pathway to Independence Award (R00 GM134154) and the Cancer Prevent and Research Institute of Texas (RR200095). J.S.W. is supported by the Howard Hughes Medical Institute. A.A.B. is supported by the Stowers Institute for Medical Research and the NIH (R01 GM136849). A.-R.C. is supported by funds provided by the Searle Scholars program, the Sloan Research Fellowship in Computational and Evolutionary Molecular Biology and the National Institute of General Medical Sciences, NIH, award number DP2GM137422. P.V.B. wishes to acknowledge the support from the Investigator in Science Award (grant number 210692/Z/18/Z) by SFI-HRB-Wellcome Trust Biomedical Research Partnership and from Russian Science Foundation (grant number 20-14-00121). N.H. is the recipient of a European Research Council advanced grant under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. AdG788970). N.H. is supported by a grant from the Leducq Foundation (11 CVD-01). The work of the HGNC is funded by the Wellcome Trust (208349/Z/17/Z) and the NHGRI, NIH (under award number U24HG003345). X.R. and M.A.B. are funded by the Canadian Institutes of Health Research, grant PJT-175322. X.R. is funded as a Canada Research Chair in functional proteomics and discovery of novel proteins. N.T.I. is supported by the NIH under award number R01 GM130996. R.L.M. and E.W.D. are supported by NIH grants R01GM087221, R24GM127667, U19AG023122, 1S10OD026936-01 and US National Science Foundation grant DBI-1933311. J.L.A. is supported by the Medical Research Council (MR/N000471/1). M.A.B. is supported by a Junior 1 fellowship from the Fonds de Recherche du Québec–Santé.
PY - 2022/7
Y1 - 2022/7
UR - http://www.scopus.com/inward/record.url?scp=85134223343&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134223343&partnerID=8YFLogxK
U2 - 10.1038/s41587-022-01369-0
DO - 10.1038/s41587-022-01369-0
M3 - Letter
C2 - 35831657
AN - SCOPUS:85134223343
SN - 1087-0156
VL - 40
SP - 994
EP - 999
JO - Nature biotechnology
JF - Nature biotechnology
IS - 7
ER -